Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Cytadren

Known as: Rodazol, Novartis Brand of Aminoglutethimide, Ciba Vision Brand of Aminoglutethimide 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Aminoglutethimide
Elipten

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Aminoglutethimide in advanced breast cancer: plasma levels and clinical results after low and high doses
SummaryDrug plasma levels, metabolism data and clinical results were evaluated after the daily administration of either 500 or 1… 
  • table 1
  • figure 3
  • figure 2
  • table 2
  • table 3
2002
2002
Identification of the aromatase inhibitor aminoglutethimide in urine by gas chromatography/mass spectrometry.
Aminoglutethimide is used therapeutically as an aromatase inhibitor in the treatment of metastatic breast cancer in post… 
Review
2001
Review
2001
Nonsteroidal and steroidal aromatase inhibitors in breast cancer.
Anastrozole (Arimidex), letrozole (Femara), and exemestane (Aromasin) are members of the third generation of aromatase inhibitors… 
1998
1998
Molecular Action and Clinical Relevance of Aromatase Inhibitors.
  • Murphy
  • The oncologist
  • 1998
  • Corpus ID: 41997957
BREAST CANCER: HIGH PREVALENCE AND RISING INCIDENCE: Breast cancer is the most common form of cancer among women in Europe, North… 
Review
1998
Review
1998
Aromatase inhibitors as potential cancer chemopreventives.
Epidemiological and experimental evidence strongly supports a role for estrogens in the development and growth of breast tumors… 
  • figure 1
  • figure 4
  • figure 2
  • figure 3
  • table I
1998
1998
Influence of dexaminoglutethimide, an optical isomer of aminoglutethimide, on the disposition of estrone sulfate in postmenopausal breast cancer patients.
Aminoglutethimide (AG) has been the most widely used aromatase inhibitor in breast cancer patients to date. Commercially, AG… 
  • figure 1
  • table 1
  • table 2
  • figure 3
  • figure 2
1998
1998
[Effect of Yangxue bushen tablet on ovarian function in animal model of Yang deficiency].
  • L. Cai, H. Li, Y. Wei
  • Zhongguo Zhong xi yi jie he za zhi Zhongguo…
  • 1998
  • Corpus ID: 24680850
OBJECTIVE To study the therapeutic mechanism of Yangxue Bushen tablet (tablet for nourishing blood and tonifying Kidney) on the… 
1986
1986
A double blind randomised clinical trial of adjuvant aminoglutethimide versus placebo given to post menopausal patients with histologically confirmed stage II breast cancer.
A multicentre double blind trial is underway to evaluate aminoglutethimide (AG) (Orimeten, Ciba) 1.000 mg/day with hydrocortisone… 
1985
1985
Aminoglutethimide and estrogenic stimulation before chemotherapy for treatment of advanced breast cancer. Preliminary results of a phase II study conducted by the E.O.R.T.C. Breast Cancer Cooperative…
While both endocrine therapy and chemotherapy are of proven value in the treatment of advanced breast cancer, the effects of… 
Highly Cited
1982
Highly Cited
1982
A randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Abstract We compared antiestrogen therapy (tamoxifen) with an estrogen suppression regimen (aminoglutethimide-hydrocortisone) in… 
  • table 1
  • table 5
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE